Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography.
Four patients with a well-established diagnosis of tuberous sclerosis and grand mal type epileptic seizures as their principal clinical symptom were examined by conventional surface electroencephalography (EEG), X-ray computed tomography, and positron emission tomography (PET) using the [18F]-2-fluoro-2-deoxyglucose method. The interictal EEG showed various abnormalities of poor localizing value, but no focal epileptic discharges. X-ray computed tomography demonstrated subependymal calcifications in all cases, although cortical lesions were found only twice. However, in the PET images of each patient one or two localized cortical foci with a metabolic rate for glucose more than 40% lower than in the respective contralateral region were clearly delineated. It may be assumed that those hypometabolic areas represent the epileptogenic cortical tubers, which are characteristic of the disease but usually cannot be detected in vivo by other methods.
D000328:Adult; D002540:Cerebral Cortex / Q000378:metabolism*; D002648:Child; D003847:Deoxyglucose / Q000031:analogs & derivatives; D004569:Electroencephalography; D004830:Epilepsy, Tonic-Clonic / Q000150:complications / Q000000981:diagnostic imaging*; D005260:Female; D005461:Fluorine; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D011868:Radioisotopes; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D014402:Tuberous Sclerosis / Q000150:complications / Q000000981:diagnostic imaging*
D011868:Radioisotopes; D019788:Fluorodeoxyglucose F18; D005461:Fluorine; D003847:Deoxyglucose